- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Global Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Results
10
2 new
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
10 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
TLRY | US$1.26 | 5.9% | -42.5% | US$1.1b | US$2.18 | PS1.4x | E71.6% | n/a | ||
2005 | HK$3.37 | -4.3% | -28.3% | HK$10.0b | HK$5.98 | PE7.3x | E6.8% | 5.3% | ||
775 | HK$0.41 | -3.6% | -33.6% | HK$3.9b | n/a | PS0.7x | n/a | 0% | ||
BIOA B New | SEK 212.80 | 23.9% | -21.2% | SEK 18.8b | SEK 322.00 | PS112.5x | E62.5% | 0% | ||
BVXP | UK£33.25 | -5.0% | -22.7% | UK£173.6m | UK£51.00 | PE21.4x | n/a | 4.7% | ||
TRJ | AU$1.04 | 2.5% | -9.6% | AU$158.4m | AU$1.45 | PS1x | E98.8% | n/a | ||
MRVI | US$5.37 | -5.3% | -18.8% | US$1.4b | US$9.07 | PS2.8x | E84.7% | n/a | ||
SNDL New | US$1.80 | 1.1% | 16.9% | US$477.9m | US$3.19 | PS0.8x | E144.4% | n/a | ||
TYRA | US$14.00 | -6.3% | 4.1% | US$736.4m | US$31.00 | PB2x | E-4.5% | n/a | ||
2487 | HK$6.83 | -3.8% | -30.3% | HK$2.2b | HK$14.72 | PS10.3x | E49.4% | n/a |
Page 1 of 1